Jaguar Health (JAGX) Change in Account Payables (2014 - 2026)
Jaguar Health's (JAGX) quarterly Change in Account Payables came in at -$3.8 million in Q1 2026, down 317.93% year-on-year from $1.7 million in Q1 2025, and down 1608.03% on a QoQ basis from $249000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Account Payables (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Change in Account Payables data on file, last reported at -$3.8 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 317.93% year-over-year to -$3.8 million in Q1 2026; TTM through Mar 2026 was -$2.1 million, a 157.45% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, up 920.12% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$3.8 million, down from $249000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for JAGX reached as high as $1.9 million in Q2 2022 and fell as low as -$3.8 million in Q1 2026.
- Historically, Change in Account Payables has averaged -$2000.0 across 5 years, with a median of $249000.0 in 2025.
- Across the five-year window, Change in Account Payables jumped 643.24% in 2022 and plunged 1138.81% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at -$489000.0 in 2022, then jumped by 62.17% to -$185000.0 in 2023, then surged by 505.95% to $751000.0 in 2024, then slumped by 66.84% to $249000.0 in 2025, then slumped by 1608.03% to -$3.8 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$3.8 million in Q1 2026, $249000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | -42.19 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 35.60 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | 16.86 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | -3.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.76 Mn |
| Mar 31, 2026 | -3.76 Mn |
| Dec 31, 2025 | 249,000.00 |
| Dec 31, 2025 | 249,000.00 |
| Sep 30, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | -438,000.00 |
| Jun 30, 2025 | -438,000.00 |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 751,000.00 |
| Dec 31, 2024 | 751,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Mar 31, 2024 | -1.66 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -185,000.00 |
| Dec 31, 2023 | -185,000.00 |